ASH News Daily 2014 - Day 3 - (Page B-1)

Read this issue online at www.hematology.org/ashnewsdaily2014_monday Follow us on Twitter using #ASH14 SCHEDULE 7:00 a.m. - 5:00 p.m. Registration West Building, Lobby - First Floor 7:00 - 8:30 a.m. Education Program 7:00 - 8:30 a.m. Simultaneous Oral Sessions 10:00 a.m. - 2:00 p.m. Exhibits Open South Building, Exhibit Hall A-C 10:00 a.m. - 8:00 p.m. Poster Session III - Viewing North Building, Hall E and West Building, West Exhibit Hall 10:30 a.m. - 12:00 noon Simultaneous Oral Sessions 10:30 a.m. - 12:00 noon Education Program 12:15 - 1:15 p.m. Product Theaters in Exhibit Hall South Building, Exhibit Hall A-C 12:15 - 1:15 p.m. Trainee Simultaneous Didactic Sessions Open only to trainees wearing a blue badge 2:45 - 4:15 p.m. Simultaneous Oral Sessions 2:45 - 4:15 p.m. Education Program 4:30 - 6:00 p.m. Simultaneous Oral Sessions 6:00 - 8:00 p.m. Poster Session III - Presentations North Building, Hall E and West Building, West Exhibit Hall 6:00 - 8:00 p.m. Poster Hall Reception North Building, Hall E and West Building, West Exhibit Hall 6:15 - 7:45 p.m. Simultaneous Oral Sessions IN THIS SECTION Joanne Levy Memorial Award B-5 Outstanding Abstract Awards B-6 ASH Scholar Awards B-7 San Francisco Travel Guide B-30 From KFC to Sloan Kettering: How Dameshek Prize Recipient Scott Armstrong Continues to Embody Humility T omorrow at 9:30 a.m. during the Announcement of Awards (North Building, Hall D [Moscone Center]), ASH will honor Scott Armstrong, MD, PhD, of Memorial Sloan Kettering Cancer Center, with the 2014 William Dameshek Prize for his exceptional work in leukemia research and cancer stem cell biology. The award, named after the late former ASH President William Dameshek, MD, recognizes an individual who has made a recent, outstanding contribution to the field of hematology. For Dr. Armstrong, that contribution has been his ongoing, groundbreaking research into the biology and epigenetics of a class of leukemias initiated by mixed lineage leukemia (MLL) gene translocations. Dr. Armstrong has spent his career attempting to uncover unique insights into the orious forms of leukemia. gin and properties of While the depth of his cancer stem cells, the research is astounding, signaling pathways Dr. Armstrong's focus sustaining cancer cell has never been on accoself-renewal, and the lades, but squarely on epigenetic mechanisms his patients. dependent on MLLWhen reflecting on fusion oncogenes. In his career, Dr. Arm2002, Dr. Armstrong strong claims that his published a seminal Pediatric Hematology/ paper in Nature GeOncology fellowship at netics demonstrating Scott Armstrong, MD, the Dana-Farber CanPhD that MLLs exhibited a cer Institute was the unique expression sigmost challenging penature. In subsequent papers pub- riod of his career in medicine. But lished in Cancer Cell in 2003 and his challenges were not only profesBlood in 2004, Dr. Armstrong de- sional - they were based on skills scribed how the FMS-like tyrosine that cannot always be taught. kinase-3 (FLT3) is highly expressed "Learning how to treat children and often mutated in MLLs. Dr. with cancer and how to have disArmstrong's findings, in conjunc- cussions with parents about their tion with the work of others, have led to clinical trials of FLT3 in vari»» DAMESHEK Page B-4 Henry M. Stratton Winners Preach Imagination, Kindness for Success T he Society will recognize pave the way for a number of new and pathologic states. In addition to both Timothy Springer, PhD, therapeutic agents. Dr. Springer, these accomplishments, his breakof Harvard Medical School, who currently serves as professor of through research discoveries have and Geraldine Schechter, MD, of biological chemistry and molecular been vital to the development of two the Veterans Affairs Medical FDA-approved drugs. Center in Washington, DC, Dr. Springer's influence with the 2014 Henry M. Stratwithin the hematologic comton Medal for their seminal munity at large cannot be overcontributions in the areas of stated. His seminal contribubasic hematology research tions are evidenced through and clinical hematology, remore than 500 publications spectively, during tomorrow's of his work and the receipt of Announcement of Awards at widespread recognition for his 9:30 a.m. research. His research accolades Dr. Springer is receiving include two National Institutes this prestigious award for of Health MERIT Grant awards his landmark contributions and his election to the National Timothy Springer, PhD Geraldine Schechter, MD to the understanding of the Academy of Sciences and the structure-function relationAmerican Academy of Arts ship of adhesion molecules, inter- pharmacology at Harvard Medical and Sciences. He credits cycling and action of blood cells with vascular School, has linked the most rigor- spending time with his five children endothelium, and detailed analysis ous and creative atomic level struc- as the activities that help to keep of shear force on von Willebrand tural information with broad cellu- him grounded outside of work. factor biology and its cleavage by lar functions, resulting in profound ADAMTS-13, which have helped implications for normal physiology »» STRATTON MEDAL Page B-3  http://www.hematology.org/ashnewsdaily2014_monday

Table of Contents for the Digital Edition of ASH News Daily 2014 - Day 3

Table of Contents

ASH News Daily 2014 - Day 3

https://www.nxtbookmedia.com